PSD3
PH and SEC7 domain-containing protein 3
Also known as: DKFZp761K1423, EFA6D, EFA6R, HCA67, KIAA0942, PSD3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NYI0
- Gene
- PSD3
- Ensembl
- ENSG00000156011
- Chromosome
- 8
- Canonical length
- 1048 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Vesicles,Cytosol,Calyx,Mid piece,Principal piece,End piece
OverviewNCBI Gene
Predicted to enable guanyl-nucleotide exchange factor activity and phospholipid binding activity. Predicted to be involved in regulation of ARF protein signal transduction. Predicted to be located in membrane. Predicted to be active in glutamatergic synapse; postsynapse; and ruffle membrane. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
1048 residues, UniProt reviewed canonical sequence.
>Q9NYI0|PSD3
1 MEGRSAAAET FVWVNNASAH SQSVAKAKYE FLFGRSEGKA PDTSDHGGST LLPPNVTNEF
61 PEYGTMEEGG EGLRASLEFD GEALPCHPQE QQGVQPLTGC HSGLDSVTEG PKDVREAPSQ
121 SHLKEQSLQP IDSLISALKA TEARIISGTL QATKVLDQDA VSSFSVQQVE KELDTASRKT
181 QRVNKTLPAG QKNLPEIPLS AEVTTEESFY LSIQKDLTAL LTGDTQAEIS QIMNNGRKGA
241 VCVQEPSCPL ASLGSSAVTC HSAGSVGFLK EQRSALGREH PGGCDRSSSM GRPGRVKHVE
301 FQGVEILWTG GDKRETQHPI DFETSLQRTA SPDSKESSKV PRHLISSAGL CNSSSLTENV
361 WDESWKAPSE RPGTSSGTFS PVRLDESGED EVFLQENKQH LEKTPKPERD RERISEQEEH
421 VKGEDEDILG PGYTEDSTDV YSSQFETILD NTSLYYSAES LETLYSEPDS YFSFEMPLTP
481 MIQQRIKEGG QFLERTSGGG HQDILSVSAD GGIVMGYSSG VTNGLNDASD SIYTKGTPEI
541 AFWGSNAGVK TTRLEAHSEM GSTEILEKET PENLSNGTSS NVEAAKRLAK RLYQLDRFKR
601 SDVAKHLGKN NEFSKLVAEE YLKFFDFTGM TLDQSLRYFF KAFSLVGETQ ERERVLIHFS
661 NRYFYCNPDT IASQDGVHCL TCAIMLLNTD LHGHVNIGKK MTCQEFIANL QGVNEGVDFS
721 KDLLKALYNS IKNEKLEWAV DDEEKKKSPS ESTEEKANGT HPKTISRIGS TTNPFLDIPH
781 DPNAAVYKSG FLARKIHADM DGKKTPRGKR GWKTFYAVLK GTVLYLQKDE YKPEKALSEE
841 DLKNAVSVHH ALASKATDYE KKPNVFKLKT ADWRVLLFQT QSPEEMQGWI NKINCVAAVF
901 SAPPFPAAIG SQKKFSRPLL PATTTKLSQE EQLKSHESKL KQITTELAEH RSYPPDKKVK
961 AKDVDEYKLK DHYLEFEKTR YEMYVSILKE GGKELLSNDE SEAAGLKKSH SSPSLNPDTS
1021 PITAKVKRNV SERKDHRPET PSIKQKVTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PSD3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 65 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 65 nTPM
- cerebral cortex: 48 nTPM
- basal ganglia: 26 nTPM
- heart muscle: 26 nTPM
- hippocampal formation: 19 nTPM
- amygdala: 19 nTPM
Single-cell type
- adrenal cortex cells: 1,568 nCPM
- bergmann glia: 1,488 nCPM
- somatotrophs: 1,346 nCPM
- cardiomyocytes: 1,236 nCPM
- early spermatids: 1,018 nCPM
- foveolar cells: 966 nCPM
Immune cell
- basophil: 0.5 nTPM
- naive B-cell: 0.5 nTPM
- T-reg: 0.4 nTPM
- memory B-cell: 0.3 nTPM
- NK-cell: 0.3 nTPM
- classical monocyte: 0.2 nTPM
Brain region
- cerebellum: 215 nTPM
- cerebral cortex: 192 nTPM
- basal ganglia: 176 nTPM
- hippocampal formation: 145 nTPM
- amygdala: 129 nTPM
- white matter: 117 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.45
- gnomAD pLI
- 0.01
- gnomAD missense Z
- -1.5
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PSD3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PSD3 as an antibody target. Whether an autoantibody or antibody against PSD3 could matter depends on whether native PSD3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PSD3 is annotated at the cell surface, where native PSD3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PSD3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...